Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Kidney Transplant Recipients
Interventions
DRUG

mycophenolic acid

Comparing mycophenolic acid 720mg orally twice daily starting 2 weeks prior to transplant to mycophenolic acid 720mg orally twice daily starting day of transplant.

Trial Locations (1)

45267

University of Cincinnati Medical Center, Cincinnati

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Cincinnati

OTHER